You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Claims for Patent: 10,071,985

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,071,985

Title:	Therapeutic compounds
Abstract:	The present disclosure relates to a compound of formula (Ia), (Ib), (IIa), and (IIb):
Inventor(s):	Graupe Michael, Henry Steven J., Link John O., Rowe Charles William, Saito Roland D., Schroeder Scott D., Stefanidis Dimitrios, Tse Winston C., Zhang Jennifer R.
Assignee:	Gilead Sciences, Inc.
Application Number:	US15680041
Patent Claims:	3. A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 2 , or a pharmaceutically acceptable salt thereof claim 2 , and a pharmaceutically acceptable excipient.6. A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 5 , or a pharmaceutically acceptable salt thereof claim 5 , and a pharmaceutically acceptable excipient.7. The pharmaceutical composition of claim 3 , wherein the composition is suitable for oral administration.8. The pharmaceutical composition of claim 7 , wherein the composition is a capsule.9. The pharmaceutical composition of claim 8 , wherein the capsule is a hard capsule.10. The pharmaceutical composition of claim 8 , wherein the capsule is a soft capsule.11. The pharmaceutical composition of claim 7 , wherein the composition comprises a dosage amount from 1 mg to 1000 mg.12. The pharmaceutical composition of claim 11 , wherein the composition comprises a dosage amount from 10 mg to 50 mg.13. The pharmaceutical composition of claim 11 , wherein the composition comprises a dosage amount from 50 mg to 300 mg.14. The pharmaceutical composition of claim 11 , wherein the composition comprises a dosage amount from 300 mg to 1000 mg.15. The compound of claim 2 , wherein the compound is an amorphous solid.16. The pharmaceutical composition of claim 6 , wherein the composition is suitable for oral administration.17. The pharmaceutical composition of claim 16 , wherein the composition is a capsule.18. The pharmaceutical composition of claim 17 , wherein the capsule is a hard capsule.19. The pharmaceutical composition of claim 17 , wherein the capsule is a soft capsule.20. The pharmaceutical composition of claim 16 , wherein the composition comprises a dosage amount from 1 mg to 1000 mg.21. The pharmaceutical composition of claim 20 , wherein the composition comprises a dosage amount from 10 mg to 50 mg.22. The pharmaceutical composition of claim 20 , wherein the composition comprises a dosage amount from 50 mg to 300 mg.23. The pharmaceutical composition of claim 20 , wherein the composition comprises a dosage amount from 300 mg to 1000 mg.24. The compound of claim 5 , wherein the compound is a pharmaceutically acceptable salt.25. The compound of claim 24 , wherein the compound is a trifluoroacetic acid salt.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.